The main findings of this study are that, in patients with type 1 diabetes, and after adjustments for confounders, higher levels of plasma HMGB1 are associated with a higher incidence of all-cause mortality and also, though to a lesser extent, fatal and non-fatal CVD. Here, HMGB1 is linked to type 1 diabetes mellitus.